
GC62299
MEISi-2
Also known as 4-hydroxy-N-[(E)-(2-hydroxynaphthalen-1-yl)methylideneamino]benzamide
MEISi-2 is a selective inhibitor of MEIS, a key regulator of hematopoietic stem cell (HSC) self-renewal· MEISi-2 is developed for the research of cardiac injuries, hematopoiesis issues, bone marrow transplantations, and cancer
ChemicalCAS2250156-71-7MW306.32FormulaC18H14N2O3
- CAS number
- 2250156-71-7
- Molecular weight
- 306.32
- Formula
- C18H14N2O3
- InChIKey
- BBWITAIHTBXEMO-YBFXNURJSA-N
- Catalogue number
- GC62299
- Brand
- GLPBIO
Computed properties PubChem CID 135613258 · XLogP 3.4 · TPSA 81.9 Ų · H-bond donors 3
- XLogP
- 3.4
- TPSA
- 81.9 Ų
- H-bond donors
- 3
- H-bond acceptors
- 4
- Rotatable bonds
- 3
- Heavy atoms
- 23
SMILES C1=CC=C2C(=C1)C=CC(=C2/C=N/NC(=O)C3=CC=C(C=C3)O)O
Computed descriptors from PubChem (CID 135613258), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il